BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV) - EverGlade Consulting

BARDA Funding for Next-Generation Therapeutics and Vaccines for COVID-19 available through Rapid Response Partnership Vehicle (RRPV)

EverGlade and BARDA funding

The Rapid Response Partnership Vehicle (RRPV) Consortium is a joint initiative with the Biomedical Research and Development Authority (BARDA) to promote research and development in response to pandemics or public health emergencies. 

Scroll to Top
A yellow lab flask with Donald Trump hair and a red tie.

Webinar: R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Join us on Jan 15, 2025, at 12:00pm ET for a deep dive into the future of R&D Funding in Life Sciences.